Amlodipine and Panophthalmitis - a phase IV clinical study of FDA data

Summary:

Panophthalmitis is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are male, 50-59 old, also take Nexavar, and have Disturbance in attention.

The phase IV clinical study analyzes which people have Panophthalmitis when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Panophthalmitis?

Panophthalmitis (inflammation of all the eye structures or tissues) is found to be associated with 21 drugs and 70 conditions by eHealthMe. Check the latest studies of Panophthalmitis.

On Jul, 21, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 12 people (0.0%) have Panophthalmitis.

Among these 12 people:

What is the gender of people who have Panophthalmitis when taking Amlodipine? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Panophthalmitis when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

Nexavar: 7 people, 58.33%
Temazepam: 6 people, 50.00%
Enalapril Maleate: 5 people, 41.67%
Omeprazole: 5 people, 41.67%
Aspirin And Dipyridamole: 4 people, 33.33%
Fentanyl: 4 people, 33.33%
Acetaminophen: 3 people, 25.00%
Vabysmo: 2 people, 16.67%
Bisoprolol Fumarate: 2 people, 16.67%
Bromfenac Sodium: 2 people, 16.67%

What are other side effects people have besides Panophthalmitis? *

Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough): 7 people, 58.33%
Speech Impairment (Adult) (inability to speak (adult)): 7 people, 58.33%
Rash Macular (small, flat red spots): 7 people, 58.33%
Oropharyngeal Discomfort (pain or irritation of oropharynx): 7 people, 58.33%
Gingival Bleeding (bleeding gums): 7 people, 58.33%
Nausea And Vomiting: 7 people, 58.33%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 58.33%
Itching: 7 people, 58.33%
Diarrhea: 6 people, 50.00%
Rashes (redness): 6 people, 50.00%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 58.33%
Pain: 7 people, 58.33%
Insomnia (sleeplessness): 7 people, 58.33%
Hepatic Neoplasm Malignant (liver cancer): 7 people, 58.33%
Disturbance In Attention: 7 people, 58.33%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Diabetes: 2 people, 16.67%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Panophthalmitis?

- Check whether Panophthalmitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,829 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Panophthalmitis:

Panophthalmitis (21 drugs)

Browse all the conditions that are associated with Panophthalmitis:

Panophthalmitis (70 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.